{"id":"W3125520517","doi":"10.1093/eurjpc/zwaa097","title":"Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Adverse effect; Statin; Familial hypercholesterolemia; Evolocumab; Tolerability; Cholesterol; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003240604,0.0006222919,0.001042937,0.0001908916,0.000413499,0.000948516,0.0004663939,0.0006476747,0.001581109],"category_scores_gemma":[0.002656099,0.0002682017,0.0008309128,0.0002472994,0.0006725797,0.0005492676,0.000551932,0.001078284,0.0003101843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007905395,"about_ca_system_score_gemma":0.001332703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001776732,"about_ca_topic_score_gemma":0.003240576,"domain_scores_codex":[0.9986518,0.0007030017,0.00008480167,0.00023771,0.0002207582,0.0001020392],"domain_scores_gemma":[0.997359,0.0004946266,0.0009223107,0.0002736058,0.0002859603,0.0006645249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4702413,0.0169549,0.3951109,0.002201449,0.006417952,0.001077985,0.001201658,0.001287275,0.01342091,0.0005293535,0.006260724,0.0852955],"study_design_scores_gemma":[0.1276874,0.1025988,0.7459722,0.0002622232,0.003622236,0.001845151,0.0004088673,0.003384726,0.003080986,0.0003847033,0.01059055,0.0001621246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963852,0.001487113,0.0001786806,0.0001674448,0.00001679835,0.0002155898,0.0006253852,0.00001151299,0.0009123666],"genre_scores_gemma":[0.9968424,0.0006394836,0.0004334774,0.0003615345,0.00005454841,0.0002042555,0.001036407,0.000005010991,0.000422867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003240604,"threshold_uncertainty_score":0.01713812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02503213564825833,"score_gpt":0.2839644164855822,"score_spread":0.2589322808373239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}